March 2021. Volume 17. Number 1

Antigenic rapid tests are of low sensitivity in the first 5 days of SARS-CoV-2 compatible symptoms in children

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Villaverde S, Domínguez-Rodríguez S, Sabrido G, Pérez-Jorge C, Plata M, Romero MP, et al. Diagnostic accuracy of the panbio sars-cov-2 antigen rapid test compared with Rt-Pcrtesting of nasopharyngeal samples in the pediatric population. J Pediatr. 2021;S0022-3476(21)00034-2.

Reviewers: Aparicio Rodrigo M1, Martín Masot R2.
1Departamento de Pediatría. Universidad Complutense de Madrid. CS Entrevías. Servicio Madrileño de Salud. Madrid. España.
2UGC Pediatría. Hospital Regional Universitario de Málaga. Málaga. España.
Correspondence: María Aparicio Rodrigo. Email: maria.aparicio.rodrigo@gmail.com
Reception date: 04/03/2021
Acceptance date: 09/03/2021
Publication date: 17/03/2021

Abstract

Authors’ conclusions: in patients with suspected COVID-19 and symptoms of less than five days of evolution, the PanbioTM rapid antigen test has poor diagnostic sensitivity.

Reviewers’ commentary: in children up to 16 years of age with symptoms compatible with COVID-19 and less than five days of evolution, a negative rapid antigenic test does not rule out SARS-CoV-2 infection and, in a situation of high suspicion of SARS-CoV-2, PCR should be considered.

How to cite this article

Aparicio Rodrigo M, Martín Masot R. Las pruebas antigénicas rápidas son poco sensibles en los 5 primeros días de síntomas compatibles con SARS-CoV-2 en niños. Evid Pediatr. 2021;17:5.

AVC | Critically appraised articles

Villaverde S, Domínguez-Rodríguez S, Sabrido G, Pérez-Jorge C, Plata M, Romero MP, et al. Diagnostic accuracy of the panbio sars-cov-2 antigen rapid test compared with Rt-Pcrtesting of nasopharyngeal samples in the pediatric population. J Pediatr. 2021;S0022-3476(21)00034-2.

Reviewers: Aparicio Rodrigo M1, Martín Masot R2.
1Departamento de Pediatría. Universidad Complutense de Madrid. CS Entrevías. Servicio Madrileño de Salud. Madrid. España.
2UGC Pediatría. Hospital Regional Universitario de Málaga. Málaga. España.
Correspondence: María Aparicio Rodrigo. Email: maria.aparicio.rodrigo@gmail.com
Reception date: 04/03/2021
Acceptance date: 09/03/2021
Publication date: 17/03/2021

How to cite this article

Aparicio Rodrigo M, Martín Masot R. Las pruebas antigénicas rápidas son poco sensibles en los 5 primeros días de síntomas compatibles con SARS-CoV-2 en niños. Evid Pediatr. 2021;17:5.

17/03/2021

Linked Comment